Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Summary sheet

    Release date
    19 March 2026
    Status
    Reference
    Approved | 11/06/2026
    20250871
    Project name
    Promoter - financial intermediary
    TECHEU TI LS & BIOTECH ACT (IEU VD) LE III
    ACCEPTABLE CORPORATE(S)
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 500 million
    EUR 1000 million
    Location
    Sector(s)
    Description
    Objectives

    The project refers to a Lending Envelope for investments comprising Thematic Venture Debt (Equity Type) operations eligible under the Thematic Innovation - Research, Innovation and Digitalisation Window (RIDW) InvestEU Window, including: 1.1. Health Innovation; and 1.3 Areas of strategic importance, as well as any additional requirement defined by the specific financing sources part of the Envelope. Previously, these operations under Thematic Innovation were included in 2023-0791 TechEU Thematic Innovation (InvestEU VD) LE II, which included Health Innovation, Future Tech and Areas of strategic importance. A separate Lending Envelope is expected for Future Tech (2025-0870 - TECHEU TI TECH (INVESTEU VD) LE III).

    The aim is to provide venture debt finance to eligible counterparts in all InvestEU eligible countries.

    Environmental aspects
    Procurement

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate

    Milestone
    Under appraisal
    Approved
    11 June 2026

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - TECHEU TI LS & BIOTECH ACT (IEU VD) LE III
    Publication Date
    12 Jun 2026
    Document language
    Main Topic
    Lending
    Document Number
    259900246
    Document Focus
    Environmental Information
    Project Number
    20250871
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications